These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 33183309)
1. Perioperative strategy and outcome in giant retroperitoneal dedifferentiated liposarcoma-results of a retrospective cohort study. Bachmann R; Eckert F; Gelfert D; Strohäker J; Beltzer C; Ladurner R World J Surg Oncol; 2020 Nov; 18(1):296. PubMed ID: 33183309 [TBL] [Abstract][Full Text] [Related]
2. Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma. Nathenson MJ; Barysauskas CM; Nathenson RA; Regine WF; Hanna N; Sausville E World J Surg Oncol; 2018 Oct; 16(1):203. PubMed ID: 30309356 [TBL] [Abstract][Full Text] [Related]
3. Multivisceral resection for retroperitoneal liposarcoma-is it worth it? A 20-year single-center experience. Teixeira FR; Arakaki MS; Lima HVG; Ferreira FO; Menegozzo CAM; Silva ER; Montero EFS; Oya T; Lima LC; Akaishi EH; Utiyama EM Surg Today; 2023 Oct; 53(10):1181-1187. PubMed ID: 37606758 [TBL] [Abstract][Full Text] [Related]
4. Significance of intraoperative radiation therapy and high cumulative radiation doses in retroperitoneal soft tissue sarcoma. Willis F; Schimmack S; Uhl M; Haefner MF; Mechtersheimer G; Hinz U; Schmidt T; Debus J; Fröhling S; Schneider M Eur J Surg Oncol; 2020 May; 46(5):905-913. PubMed ID: 31892479 [TBL] [Abstract][Full Text] [Related]
5. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Singer S; Antonescu CR; Riedel E; Brennan MF Ann Surg; 2003 Sep; 238(3):358-70; discussion 370-1. PubMed ID: 14501502 [TBL] [Abstract][Full Text] [Related]
6. Experience with surgical treatment of retroperitoneal soft tissue sarcomas at a university hospital in Thailand. Sriussadaporn S; Sriussadaporn S; Pak-art R; Kritayakirana K; Prichayudh S; Samorn P J Med Assoc Thai; 2014 Jun; 97(6):598-614. PubMed ID: 25137877 [TBL] [Abstract][Full Text] [Related]
7. Retroperitoneal liposarcomas: the experience of a tertiary Asian center. Lee SY; Goh BK; Teo MC; Chew MH; Chow PK; Wong WK; Ooi LL; Soo KC World J Surg Oncol; 2011 Feb; 9():12. PubMed ID: 21284868 [TBL] [Abstract][Full Text] [Related]
8. Successful Re-resection for Locally Recurrent Retroperitoneal Liposarcoma at Four Years After Ex Vivo Tumor Resection and Autotransplantation of the Liver: A Case Report. Kobayashi T; Miura K; Ishikawa H; Soma D; Zhang Z; Yuza K; Hirose Y; Takizawa K; Nagahashi M; Sakata J; Kameyama H; Kosugi S; Wakai T Transplant Proc; 2016 May; 48(4):1215-7. PubMed ID: 27320590 [TBL] [Abstract][Full Text] [Related]
9. Management of high-grade retroperitoneal liposarcomas: personal experience. Milone M; Pezzullo LS; Salvatore G; Pezzullo MG; Leongito M; Esposito I; Milone F Updates Surg; 2011 Jun; 63(2):119-24. PubMed ID: 21455814 [TBL] [Abstract][Full Text] [Related]
10. Retroperitoneal soft-tissue sarcomas: prognosis and treatment of primary and recurrent disease. Bautista N; Su W; O'Connell TX Am Surg; 2000 Sep; 66(9):832-6. PubMed ID: 10993610 [TBL] [Abstract][Full Text] [Related]
11. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery. Keung EZ; Hornick JL; Bertagnolli MM; Baldini EH; Raut CP J Am Coll Surg; 2014 Feb; 218(2):206-17. PubMed ID: 24315890 [TBL] [Abstract][Full Text] [Related]
12. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas. Fabre-Guillevin E; Coindre JM; Somerhausen Nde S; Bonichon F; Stoeckle E; Bui NB Cancer; 2006 Jun; 106(12):2725-33. PubMed ID: 16688768 [TBL] [Abstract][Full Text] [Related]
14. Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule. Park JO; Qin LX; Prete FP; Antonescu C; Brennan MF; Singer S Ann Surg; 2009 Dec; 250(6):977-82. PubMed ID: 19953716 [TBL] [Abstract][Full Text] [Related]
15. Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana. Erzen D; Sencar M; Novak J J Surg Oncol; 2005 Jul; 91(1):1-9. PubMed ID: 15999353 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors predicting the postoperative survival period following treatment for primary retroperitoneal liposarcoma. Zhao X; Li P; Huang X; Chen L; Liu N; She Y Chin Med J (Engl); 2015 Jan; 128(1):85-90. PubMed ID: 25563319 [TBL] [Abstract][Full Text] [Related]
17. Preoperative radiation therapy combined with radical surgical resection is associated with a lower rate of local recurrence when treating unifocal, primary retroperitoneal liposarcoma. Molina G; Hull MA; Chen YL; DeLaney TF; De Amorim Bernstein K; Choy E; Cote G; Harmon DC; Mullen JT; Haynes AB J Surg Oncol; 2016 Dec; 114(7):814-820. PubMed ID: 27634478 [TBL] [Abstract][Full Text] [Related]
18. Personalizing surgical margins in retroperitoneal sarcomas. Callegaro D; Fiore M; Gronchi A Expert Rev Anticancer Ther; 2015 May; 15(5):553-67. PubMed ID: 25797538 [TBL] [Abstract][Full Text] [Related]
19. The importance of surgical margins in retroperitoneal sarcoma. Kirane A; Crago AM J Surg Oncol; 2016 Mar; 113(3):270-6. PubMed ID: 26707028 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant Palbociclib May be Associated with Delayed Recurrence in Completely Resected Retroperitoneal Liposarcoma: Results of a Single-Institution Retrospective Cohort Study. Selby LV; Clark EC; Liebner DA; Chen JL; Tinoco G; Bashian E; Beane JD; Pollock RE; Grignol VP Ann Surg Oncol; 2023 Nov; 30(12):7876-7881. PubMed ID: 37330448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]